US Stock MarketDetailed Quotes

TYRA BIOSCIENCES, INC. (TYRA)

Watchlist
  • 37.040
  • +0.530+1.45%
Close May 15 16:00 ET
  • 37.040
  • 0.0000.00%
Post 20:01 ET
2.20BMarket Cap-16.99P/E (TTM)

TYRA BIOSCIENCES, INC. (TYRA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-27.94%-32.57M
-36.36%-95.14M
-20.59%-23.62M
-25.04%-22.38M
-130.84%-23.68M
-15.57%-25.46M
-39.16%-69.77M
-44.77%-19.59M
-4.39%-17.9M
-6.69%-10.26M
Net income from continuing operations
-39.64%-39.31M
-38.70%-119.95M
-32.31%-33.83M
-24.37%-29.87M
-50.24%-28.1M
-54.72%-28.15M
-25.09%-86.48M
-12.01%-25.57M
-13.54%-24.02M
-40.91%-18.7M
Depreciation and amortization
-3.50%138K
5.20%546K
-8.33%132K
3.15%131K
11.11%140K
17.21%143K
45.38%519K
41.18%144K
53.01%127K
41.57%126K
Change In working capital
59.27%-1.23M
-123.32%-1.63M
710.38%2.58M
765.22%199K
-124.14%-1.39M
56.02%-3.01M
-111.46%-729K
-94.92%318K
105.08%23K
455.73%5.77M
-Change in prepaid assets
8.59%-2.44M
-2,905.92%-5.08M
121.12%404K
6.30%-1.89M
-124.40%-928K
-6,102.33%-2.67M
94.01%-169K
-275.99%-1.91M
61.58%-2.02M
2,070.47%3.8M
-Change in payables and accrued expense
427.40%1.2M
552.82%3.37M
-2.36%2.16M
2.83%2.07M
-125.28%-491K
94.71%-365K
-107.94%-744K
-56.50%2.21M
-56.67%2.01M
16.15%1.94M
-Change in other working capital
-22.73%17K
-54.89%83K
-26.09%17K
-29.63%19K
-13.79%25K
-79.05%22K
198.92%184K
-75.53%23K
-82.12%27K
106.59%29K
Cash from discontinued investing activities
Operating cash flow
-27.94%-32.57M
-36.36%-95.14M
-20.59%-23.62M
-25.04%-22.38M
-130.84%-23.68M
-15.57%-25.46M
-39.16%-69.77M
-44.77%-19.59M
-4.39%-17.9M
-6.69%-10.26M
Investing cash flow
Cash flow from continuing investing activities
-475.46%-120.24M
173.64%72.46M
394.06%34.38M
-168.68%-14.81M
114.39%20.87M
77.20%32.03M
31.95%-98.4M
104.82%6.96M
26,072.29%21.56M
-337,088.37%-144.99M
Net PPE purchase and sale
-528.57%-88K
78.77%-141K
-850.00%-57K
25.00%-39K
93.40%-31K
89.71%-14K
13.77%-664K
99.00%-6K
37.35%-52K
-993.02%-470K
Net investment purchase and sale
-475.02%-120.16M
174.28%72.6M
394.46%34.43M
-168.34%-14.77M
114.46%20.9M
75.96%32.04M
32.05%-97.74M
104.84%6.96M
--21.61M
---144.52M
Cash from discontinued investing activities
Investing cash flow
-475.46%-120.24M
173.64%72.46M
394.06%34.38M
-168.68%-14.81M
114.39%20.87M
77.20%32.03M
31.95%-98.4M
104.82%6.96M
26,072.29%21.56M
-337,088.37%-144.99M
Financing cash flow
Cash flow from continuing financing activities
7,233.47%160.38M
-95.99%8.1M
563.31%4.68M
-12.92%647K
56.30%583K
-98.91%2.19M
13,051.40%202.14M
117.90%706K
59.10%743K
0.81%373K
Net common stock issuance
--147.85M
--0
--0
--0
--0
--0
--199.58M
--0
--0
---251K
Proceeds from stock option exercised by employees
472.93%12.53M
216.78%8.1M
563.31%4.68M
-12.92%647K
-6.57%583K
351.86%2.19M
66.36%2.56M
117.90%706K
59.10%743K
68.65%624K
Cash from discontinued financing activities
Financing cash flow
7,233.47%160.38M
-95.99%8.1M
563.31%4.68M
-12.92%647K
56.30%583K
-98.91%2.19M
13,051.40%202.14M
117.90%706K
59.10%743K
0.81%373K
Net cash flow
Beginning cash position
-15.68%78.39M
57.55%92.97M
-39.98%62.95M
-1.00%99.49M
-60.17%101.72M
57.55%92.97M
-76.60%59.01M
-51.59%104.89M
-56.95%100.49M
5.22%255.37M
Current changes in cash
-13.56%7.57M
-142.93%-14.58M
229.43%15.44M
-930.05%-36.54M
98.56%-2.23M
-95.54%8.76M
117.58%33.96M
92.43%-11.93M
126.26%4.4M
-1,567.48%-154.88M
End cash Position
-15.50%85.96M
-15.68%78.39M
-15.68%78.39M
-39.98%62.95M
-1.00%99.49M
-60.17%101.72M
57.55%92.97M
57.55%92.97M
-51.59%104.89M
-56.95%100.49M
Free cash flow
-28.22%-32.66M
-35.27%-95.28M
-20.85%-23.68M
-24.90%-22.42M
-121.02%-23.71M
-14.93%-25.47M
-38.36%-70.44M
-38.63%-19.6M
-4.19%-17.95M
-11.08%-10.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -27.94%-32.57M-36.36%-95.14M-20.59%-23.62M-25.04%-22.38M-130.84%-23.68M-15.57%-25.46M-39.16%-69.77M-44.77%-19.59M-4.39%-17.9M-6.69%-10.26M
Net income from continuing operations -39.64%-39.31M-38.70%-119.95M-32.31%-33.83M-24.37%-29.87M-50.24%-28.1M-54.72%-28.15M-25.09%-86.48M-12.01%-25.57M-13.54%-24.02M-40.91%-18.7M
Depreciation and amortization -3.50%138K5.20%546K-8.33%132K3.15%131K11.11%140K17.21%143K45.38%519K41.18%144K53.01%127K41.57%126K
Change In working capital 59.27%-1.23M-123.32%-1.63M710.38%2.58M765.22%199K-124.14%-1.39M56.02%-3.01M-111.46%-729K-94.92%318K105.08%23K455.73%5.77M
-Change in prepaid assets 8.59%-2.44M-2,905.92%-5.08M121.12%404K6.30%-1.89M-124.40%-928K-6,102.33%-2.67M94.01%-169K-275.99%-1.91M61.58%-2.02M2,070.47%3.8M
-Change in payables and accrued expense 427.40%1.2M552.82%3.37M-2.36%2.16M2.83%2.07M-125.28%-491K94.71%-365K-107.94%-744K-56.50%2.21M-56.67%2.01M16.15%1.94M
-Change in other working capital -22.73%17K-54.89%83K-26.09%17K-29.63%19K-13.79%25K-79.05%22K198.92%184K-75.53%23K-82.12%27K106.59%29K
Cash from discontinued investing activities
Operating cash flow -27.94%-32.57M-36.36%-95.14M-20.59%-23.62M-25.04%-22.38M-130.84%-23.68M-15.57%-25.46M-39.16%-69.77M-44.77%-19.59M-4.39%-17.9M-6.69%-10.26M
Investing cash flow
Cash flow from continuing investing activities -475.46%-120.24M173.64%72.46M394.06%34.38M-168.68%-14.81M114.39%20.87M77.20%32.03M31.95%-98.4M104.82%6.96M26,072.29%21.56M-337,088.37%-144.99M
Net PPE purchase and sale -528.57%-88K78.77%-141K-850.00%-57K25.00%-39K93.40%-31K89.71%-14K13.77%-664K99.00%-6K37.35%-52K-993.02%-470K
Net investment purchase and sale -475.02%-120.16M174.28%72.6M394.46%34.43M-168.34%-14.77M114.46%20.9M75.96%32.04M32.05%-97.74M104.84%6.96M--21.61M---144.52M
Cash from discontinued investing activities
Investing cash flow -475.46%-120.24M173.64%72.46M394.06%34.38M-168.68%-14.81M114.39%20.87M77.20%32.03M31.95%-98.4M104.82%6.96M26,072.29%21.56M-337,088.37%-144.99M
Financing cash flow
Cash flow from continuing financing activities 7,233.47%160.38M-95.99%8.1M563.31%4.68M-12.92%647K56.30%583K-98.91%2.19M13,051.40%202.14M117.90%706K59.10%743K0.81%373K
Net common stock issuance --147.85M--0--0--0--0--0--199.58M--0--0---251K
Proceeds from stock option exercised by employees 472.93%12.53M216.78%8.1M563.31%4.68M-12.92%647K-6.57%583K351.86%2.19M66.36%2.56M117.90%706K59.10%743K68.65%624K
Cash from discontinued financing activities
Financing cash flow 7,233.47%160.38M-95.99%8.1M563.31%4.68M-12.92%647K56.30%583K-98.91%2.19M13,051.40%202.14M117.90%706K59.10%743K0.81%373K
Net cash flow
Beginning cash position -15.68%78.39M57.55%92.97M-39.98%62.95M-1.00%99.49M-60.17%101.72M57.55%92.97M-76.60%59.01M-51.59%104.89M-56.95%100.49M5.22%255.37M
Current changes in cash -13.56%7.57M-142.93%-14.58M229.43%15.44M-930.05%-36.54M98.56%-2.23M-95.54%8.76M117.58%33.96M92.43%-11.93M126.26%4.4M-1,567.48%-154.88M
End cash Position -15.50%85.96M-15.68%78.39M-15.68%78.39M-39.98%62.95M-1.00%99.49M-60.17%101.72M57.55%92.97M57.55%92.97M-51.59%104.89M-56.95%100.49M
Free cash flow -28.22%-32.66M-35.27%-95.28M-20.85%-23.68M-24.90%-22.42M-121.02%-23.71M-14.93%-25.47M-38.36%-70.44M-38.63%-19.6M-4.19%-17.95M-11.08%-10.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More